The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review
Massimo Valerio, Hashim U Ahmed, Mark Emberton, Nathan Lawrentschuk, Massimo Lazzeri, Rodolfo Montironi, Paul L Nguyen, John Trachtenberg, Thomas J Polascik
European Urology | ELSEVIER | Published : 2014
Awarded by Medical Research Council
Awarded by Pelican Cancer Foundation
Awarded by Prostate Cancer UK
Massimo Valerio certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: The SICPA foundation supports the ongoing fellowship and PhD program of M. Valerio. M. Emberton and H. U. Ahmed would like to acknowledge funding from the Medical Research Council (UK), the Pelican Cancer Foundation charity, Prostate Cancer UK, St Peters Trust charity, Prostate Cancer Research Centre, the Wellcome Trust, National Institute of Health Research-Health Technology Assessment program, and the US National Institutes of Health National Cancer Institute. M. Emberton receives funding in part from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre. M. Emberton and H. U. Ahmed receive funding from USHIFU, GSK and Advanced Medical Diagnostics for clinical trials. M. Emberton is a paid consultant to Steba Biotech and USHIFU. Both have previously received consultancy payments from Oncura/GE Healthcare and Steba Biotech.